Gangliosides and neutral glycosphingolipids in human brain tumors: specificity and their significance
Eto, Y.; Shinoda, S.
Advances in Experimental Medicine and Biology 152: 279-290
1982
ISSN/ISBN: 0065-2598 PMID: 7136917 Document Number: 187874
Document emailed within 1 workday
Related Documents
Radić, B.; Vukelić, Z.; Bognar, S.K. 2008: Serum gangliosides in patients with brain tumors Collegium Antropologicum 32(Suppl 1): 171-175Stio, M.; Giachetti, E.; Vanni, P.; Pinzauti, G. 1987: Substrate specificity and kinetic properties of neutral maltase of human granulocytes Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 181(5): 553-559
Diatlovitskaia, E.V.; Tekieva, E.A.; Lemenovskaia, A.F.; Somova, O.G.; Bergel'son, L.D. 1991: Gangliosides GM3 and GD3 in human stomach and breast tumors Biokhimiia 56(3): 560-564
Ullman, M.D.; McCluer, R.H. 1987: High-pressure liquid chromatography analysis of neutral glycosphingolipids: perbenzoylated mono-, di-, tri-, and tetraglycosylceramides Methods in Enzymology 138: 117-125
Saito, K.; Sato, T. 1990: Clinical significance of human leucocyte neutral proteases analysis in the diagnosis of diabetic angiopathies Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 406-411
Gregson, N.A.; Koblar, S.; Hughes, R.A. 1993: Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features Quarterly Journal of Medicine 86(2): 111-117
Berezin, V.A.; Shevtsova, A.I.; Segal, I.B. 1984: Tissue specificity of the human brain protein D2 Biokhimiia 49(5): 742-748
Boguslavskiĭ, V.L.; Serebrennikov, I.M. 1993: The forensic medical significance of brain tumors Sudebno-Meditsinskaia Ekspertiza 36(2): 5-6
Demchuk, A.I. 1973: Diagnostic significance of plethysmography in tumors of the brain Vrachebnoe Delo 2: 114-117
Oshima, M.; Inoue, T.; Takenaka, O.; Hara, M. 1983: Antigenic region of beta-chain of human hemoglobin with species specificity--forensic immunological studies on human specificity, report-XI Nihon Hoigaku Zasshi 37(1): 45-52
Assimakopoulou, M.; Sotiropoulou-Bonikou, G.; Maraziotis, T.; Varakis, I. 1997: Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study Anticancer Research 17(4a): 2677-2682
Baev, V.I.; Vasil'eva, I.V.; Nalivaeva, N.N. 1994: Rat brain gangliosides in hypoxia Biulleten' Eksperimental'noi Biologii i Meditsiny 118(7): 19-21
Kracun, I.; Kalanj, S.; Cosovic, C.; Talan-Hranilovic, J. 1990: Brain gangliosides in Alzheimer's disease Journal für Hirnforschung 31(6): 789-793
Toffano, G.; Savoini, G.; Aldinio, C.; Valenti, G.; Dal Toso, R.; Leon, A.; Calza, L.; Zini, I.; Agnati, L.F.; Fuxe, K. 1984: Effects of gangliosides on the functional recovery of damaged brain Advances in Experimental Medicine and Biology 174: 475-488
Fomina-Ageeva, E.V.; Diatlovitskaia, E.V.; Lemenovskaia, A.F.; Bergel'son, L.D. 1987: Glycosphingolipids from human T-lymphoma MOLT-4 cells Biokhimiia 52(11): 1777-1780
Husain, I.; Mohler, J.L.; Seigler, H.F.; Besterman, J.M. 1994: Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy Cancer Research 54(2): 539-546
Paglini, S.; Zapata, M.T. 1975: Swiss albino mouse brain gangliosides: biophysical studies Acta Physiologica Latino Americana 25(3): 188-196
Biewenga, J.; Faber, A.; de Lange, G. 1987: Domain-specificity and assay-specificity of monoclonal antibodies against human IgA Advances in Experimental Medicine and Biology 216b: 1239-1249
Yoshida, J. 1983: Monoclonal antibodies against human brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(7): 1706-1714
Rosenblum, M.L. 1980: Chemosensitivity testing for human brain tumors Progress in Clinical and Biological Research 48: 259-276